Evidence map›Paper›PMID 39830240›Full record

ArticlemedRxiv : the preprint server for health sciences2025

A Method for Sensitivity Analysis of Automatic Contouring Algorithms Across Different MRI Contrast Weightings Using SyntheticMR.

Lucas McCullum, Zayne Belal, Warren Floyd, Alaa Mohamed Shawky Ali, Natalie West, Samuel Mulder, Yao Ding, Jiaofeng Xu, Dan Thill, Nicolette O'Connell and 5 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Lucas McCullumUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.ORCID 0000-0001-9788-7987
Zayne BelalDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0009-0006-2668-9717
Warren FloydDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0003-4371-8453
Alaa Mohamed Shawky AliDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-7472-3701
Natalie WestUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.ORCID 0009-0007-0211-8845
Samuel MulderUT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.ORCID 0000-0001-5185-4805
Yao DingDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-0559-5846
Jiaofeng XuElekta AB, Stockholm, Sweden.
Dan ThillElekta AB, Stockholm, Sweden.
Nicolette O'ConnellElekta AB, Stockholm, Sweden.
Joseph StancanelloElekta AB, Stockholm, Sweden.
Kareem A WahidDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-0503-0175
David T FuentesDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-2572-6962
Ken-Pin HwangDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-8196-3794
Clifton D FullerDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-5264-3994

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Targeting the p53 pathway for reversal of oral premalignancyP50CA097007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LEE, HO-YOUNG · 2002 to 2012
$26.1M
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac deviceR01DE028290 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHRISTODOULEAS, JOHN PAUL, FULLER, CLIFTON DAVID · 2019 to 2023
$4.3M
NRSA Training CoreTL1TR003169 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHANDRA, JOYA, FROST, JEFFREY A. · 2019 to 2023
$3.7M
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR01DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2016 to 2020
$2.9M
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck CancerR01CA257814 · NCI · RICE UNIVERSITY · PI FULLER, CLIFTON DAVID, SCHAEFER, ANDREW J · 2021 to 2024
$1.8M
Image Guided Cancer Therapy Training ProgramT32CA261856 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kristy Brock, Clifton David Fuller · 2022 to 2026
$1.2M
SMART-ACT: Spatial Methodologic Approaches for Risk Assessment and Therapeutic Adaptation in Cancer TreatmentR01CA214825 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CANAHUATE, GUADALUPE, FULLER, CLIFTON DAVID · 2017 to 2019
$1.1M
imaging Radiation-Associated Dysphagia (iRAD)R01CA218148 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FULLER, CLIFTON DAVID, HUTCHESON, KATHERINE ARNOLD · 2017 to 2019
$810k
QuBBD: Precision E –Radiomics for Dynamic Big Head & Neck Cancer Data R01CA225190 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CANAHUATE, GUADALUPE, FULLER, CLIFTON DAVID · 2017 to 2019
$776k
Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER)R25EB025787 · NIBIB · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DAS, PRAJNAN, FULLER, CLIFTON DAVID · 2018 to 2022
$535k
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR56DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2015 to 2015
$470k
NCATS NIH HHS TL1 TR003169NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA097007NCI NIH HHS R01 CA214825NCI NIH HHS R01 CA218148NCI NIH HHS R01 CA225190NCI NIH HHS R01 CA257814NCI NIH HHS T32 CA261856NIBIB NIH HHS R25 EB025787NIDCR NIH HHS R01 DE025248NIDCR NIH HHS R01 DE028290NIDCR NIH HHS R56 DE025248
6 · The paper itself

Abstract

Background: Currently, a majority of institution-specific automatic MRI-based contouring algorithms are trained, tested, and validated on one contrast weighting (i.e., T2-weighted), however their actual performance within this contrast weighting (i.e., across different repetition times, TR, and echo times, TE) is under-investigated and poorly understood. As a result, external institutions with different scan protocols for the same contrast weighting may experience sub-optimal performance. Purpose: The purpose of this study was to develop a method to evaluate the robustness of automatic contouring algorithms to varying MRI contrast weightings. Methods: One healthy volunteer and one patient was scanned using SyntheticMR on the MR-Simulation device. The parotid and submandibular glands in these subjects were contoured using an automatic contouring algorithm trained on T2-weighted MRIs. For ground truth manual contours, two radiation oncology residents and one pre-resident physician were recruited and their STAPLE consensus was determined. A total of 216 different MRI TR and TE combinations were simulated across T1-, T2-, and PD-weighted contrast ranges using SyntheticMR's post-processing software, SyMRI. Comparisons between automatic contouring algorithm contours and the ground truth were determined using the Dice similarity coefficient (DSC) and 95 Results: Notable differences in the automatic contouring model's performance were seen across the contrast-weighted range, even within the T2-weighted range. Further, some models even performed as well or better across subsets of the T1-weighted range. The PD-weighted range saw the worst performance. The range of discrepancy in DSC and HD95 exceeded 0.2 and 3.66 mm, respectively, in some structures. In the T2-weighted contrast region where the model was trained, 100%, 40%, 24%, and 57% for the DSC in the left parotid, right parotid, left submandibular, and right submandibular gland, respectively, exceeded interobserver variability. Conclusions: This study demonstrates the variable performance of MRI-based automatic contouring algorithms across varying TR and TE combinations. This methodology could be applied in future studies as a method for evaluating model sensitivity, out of distribution detection ability, and performance drift.

Indexed as

Automatic Contouring Sensitivity AnalysisContouringHead and Neck CancerMRISegmentationSyMRISyntheticMR

Identifiers

PMID39830240
PMCPMC11741493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.